Eritrea vs Ghana: Cause of death, by non-communicable diseases, ages 0-4
Eritrea
12.6%
in 2021
Ghana
11.6%
in 2021
Eritrea rank
138th
Ghana rank
140th
Cause of death, by non-communicable diseases, ages 0-4 over time
- Eritrea
- Ghana
How they compare
Eritrea currently reports 12.6% against 11.6% in Ghana, a difference of 1.0%.
That makes Eritrea's figure about 1.1 times Ghana's.
Across all 6 years both countries report, Eritrea has been ahead every year.
Eritrea ranks 138th and Ghana ranks 140th of 185 countries.
Eritrea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.1% | 5.0% | 3.1% | Eritrea |
| 2010s | 11.1% | 9.0% | 2.1% | Eritrea |
| 2020s | 12.5% | 11.4% | 1.1% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Eritrea or Ghana?
- Eritrea, at 12.6% against 11.6% in Ghana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Eritrea and Ghana?
- 1.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Ghana?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and Ghana rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Eritrea ranks 138th and Ghana ranks 140th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.